Procyon Advisors, LLC Revance Therapeutics, Inc. Transaction History

Procyon Advisors, LLC

  • $1.44 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Oct 22, 2020
SELL
$23.23 - $34.3 $44,137 - $65,169
-1,900 Closed
0 $0
Q2 2020

Aug 14, 2020
BUY
$12.6 - $26.55 $2,520 - $5,310
200 Added 11.76%
1,900 $46,000
Q4 2019

Feb 21, 2020
BUY
$11.66 - $20.15 $19,822 - $34,255
1,700 New
1,700 $28,000

About Revance Therapeutics, Inc.

RVNC Quotes by TradingView
  • Ticker RVNC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 82,305,696
  • Market Cap $212M
  • Description
  • Revance Therapeutics, Inc., a biotechnology company, engages in the development, manufacture, and commercialization of neuromodulators for various aesthetic and therapeutic indications in the United States and internationally. The company's lead drug candidate is DaxibotulinumtoxinA for injection, which has completed phase III clinical trials fo...
More about RVNC
Track This Portfolio

Track Procyon Advisors, LLC Portfolio

Follow Procyon Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Procyon Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Procyon Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email